BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26685729)

  • 1. Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis.
    Zhao L; Li J; Tian Z; Fang Q
    J Cardiol; 2016 Nov; 68(5):426-430. PubMed ID: 26685729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of fragmented QRS in cardiac AL amyloidosis.
    Perlini S; Salinaro F; Cappelli F; Perfetto F; Bergesio F; Alogna A; Mussinelli R; Boldrini M; Raimondi A; Musca F; Palladini G; Merlini G
    Int J Cardiol; 2013 Sep; 167(5):2156-61. PubMed ID: 22748496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Dalos D; Mascherbauer J; Zotter-Tufaro C; Duca F; Kammerlander AA; Aschauer S; Bonderman D
    J Am Coll Cardiol; 2016 Jul; 68(2):189-99. PubMed ID: 27386773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.
    Nagano N; Yano T; Fujita Y; Kouzu H; Koyama M; Ikeda H; Yasui K; Muranaka A; Nishikawa R; Takahashi R; Kishiue N; Yuda S; Miura T
    Heart Vessels; 2020 Apr; 35(4):521-530. PubMed ID: 31559459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis.
    Austin BA; Duffy B; Tan C; Rodriguez ER; Starling RC; Desai MY
    Am J Cardiol; 2009 May; 103(10):1429-33. PubMed ID: 19427441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
    Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
    Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis.
    Perlini S; Salinaro F; Musca F; Mussinelli R; Boldrini M; Raimondi A; Milani P; Foli A; Cappelli F; Perfetto F; Palladini G; Rapezzi C; Merlini G
    J Hypertens; 2014 May; 32(5):1121-31; discussion 1131. PubMed ID: 24509117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors and Prognostic Role of Left Atrial Enlargement in Patients with Cardiac Light-Chain Amyloidosis.
    Zhao L; Tian Z; Fang Q
    Am J Med Sci; 2016 Mar; 351(3):271-8. PubMed ID: 26992256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis.
    Kristen AV; Perz JB; Schonland SO; Hansen A; Hegenbart U; Sack FU; Goldschmidt H; Katus HA; Dengler TJ
    J Heart Lung Transplant; 2007 Dec; 26(12):1313-9. PubMed ID: 18096484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Amyloid Load: A Prognostic and Predictive Biomarker in Patients With Light-Chain Amyloidosis.
    Kristen AV; Brokbals E; Aus dem Siepen F; Bauer R; Hein S; Aurich M; Riffel J; Behrens HM; Krüger S; Schirmacher P; Katus HA; Röcken C
    J Am Coll Cardiol; 2016 Jul; 68(1):13-24. PubMed ID: 27364045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis.
    Slivnick JA; Wallner AL; Vallakati A; Truong VT; Mazur W; Elamin MB; Tong MS; Raman SV; Zareba KM
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1043-1051. PubMed ID: 33068247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis.
    Apridonidze T; Steingart RM; Comenzo RL; Hoffman J; Goldsmith Y; Bella JN; Landau H; Liu JE
    Am J Cardiol; 2012 Oct; 110(8):1180-4. PubMed ID: 22770934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis.
    Mohty D; Pibarot P; Dumesnil JG; Darodes N; Lavergne D; Echahidi N; Virot P; Bordessoule D; Jaccard A
    Arch Cardiovasc Dis; 2011 Dec; 104(12):611-8. PubMed ID: 22152513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Prognosis in Light-Chain Amyloidosis and Chronological Changes in Cardiac Morphology and Function.
    Amano M; Izumi C; Nishimura S; Kuroda M; Sakamoto J; Tamaki Y; Enomoto S; Miyake M; Tamura T; Kondo H; Nakagawa Y
    Am J Cardiol; 2017 Dec; 120(11):2041-2048. PubMed ID: 28947306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis without increased left ventricular wall thickness.
    Lee GY; Kim K; Choi JO; Kim SJ; Kim JS; Choe YH; Grogan MA; Jeon ES
    Mayo Clin Proc; 2014 Jun; 89(6):781-9. PubMed ID: 24702732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis.
    Milani P; Dispenzieri A; Scott CG; Gertz MA; Perlini S; Mussinelli R; Lacy MQ; Buadi FK; Kumar S; Maurer MS; Merlini G; Hayman SR; Leung N; Dingli D; Klarich KW; Lust JA; Lin Y; Kapoor P; Go RS; Pellikka PA; Hwa YL; Zeldenrust SR; Kyle RA; Rajkumar SV; Grogan M
    Circ Cardiovasc Imaging; 2018 May; 11(5):e006588. PubMed ID: 29752392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study.
    Migrino RQ; Harmann L; Christenson R; Hari P
    Heart Vessels; 2014 Nov; 29(6):793-800. PubMed ID: 24141988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.